![Francesco Marincola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francesco M.
Marincola currently works at Orna Therapeutics, Inc., as Director.
Dr. Marincola also formerly worked at Gilead Sciences, Inc., as SVP & Global Head of Cell Therapy Research of Kite, Refuge Biotechnologies, Inc., as Chief Scientific Officer from 2018 to 2020, and Kite Pharma, Inc., as Global Head-Cell Therapy Research.
| Sociétés | Poste | Début |
|---|---|---|
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| KITE PHARMA INC | Directeur Technique/Scientifique/R&D | - |
| GILEAD SCIENCES, INC. | Private Equity Investor | - |
Refuge Biotechnologies, Inc.
 Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic cells | President | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Refuge Biotechnologies, Inc.
Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic cells | Commercial Services |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
